Search results - 8 results

Estimates of the HIV undiagnosed population in Belgium reveals higher prevalence for MSM with foreign nationality and for geographic areas hosting big cities

areas: the province of Antwerp and the other provinces, because Antwerp is the second largest city after Brussels. Population sizes were determined using data from the Belgian Statistical Office and ...

High uptake of pre-exposure prophylaxis (PrEP) during early roll-out in Belgium: results from surveillance reports

prefer a non-daily regimen. A better understanding is needed as to why other populations, such as sub-Saharan African migrants, are not accessing PrEP, as well as the development of a more sustainable PrEP ...

Prevalence of drug use during sex amongst MSM in Europe: Results from a multi-site bio-behavioural survey.

(10.5% vs. 3.9%) before and with other STI s during the 12 months prior to the study (16.7% vs. 9.2%). The use of all the analysed substances was significantly associated with sexual encounter with more ...

Current levels of gonorrhoea screening in MSM in Belgium may have little effect on prevalence: a modelling study.

network, both with main and casual partners. Next, the transmission of Gonorrhoea is simulated on this network. The models are implemented using the R package ‘statnet’, which we adapted among other things ...

Bio-behavioural HIV and STI surveillance among men who have sex with men in Europe: the Sialon II protocols.

epidemiology of HIV and other STI s over time across Europe. Therefore, the Sialon II protocol and findings are likely to contribute significantly to increasing the comparability of data in EU countries through ...

Risk factors for HCV acquisition among HIV-positive MSM in Belgium.

the year before inclusion in the study (AOR = 4.50, 95% CI: 1.11 to 18.31) were independently associated with incident HCV  infection. CONCLUSIONS: Our study confirmed fisting and suffering from other ...

A venue-based HIV prevalence and behavioural study among men who have sex with men in Antwerp and Ghent, Flanders, Belgium, October 2009 to March 2010.

testing for HIV (52.2%; 95 % CI: 47.8–56.2; n=288) and other sexually transmitted infections (STI s) (57.4%; 95% CI: 52.6–62.0; n=248) in the last 12 months. A majority of the men (n=233) used condoms ...

Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.

was 10.5% (95% CI, 8.9-12.3%) with HPV16 and HPV18 detected in 2.3% and 0.9% of the samples, respectively. Excellent agreement for presence or absence of HPV16, HPV18 and other hrHPV between Linear ...

QR code

QR code for this page URL